Subscribe to Journal
Get full journal access for 1 year
only $33.25 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Tax calculation will be finalised during checkout.
Rent or Buy article
Get time limited or full article access on ReadCube.
All prices are NET prices.
White R, Rose K, Zon L. Zebrafish cancer: the state of the art and the path forward. Nat Rev Cancer. 2013;13:624–36.
Langenau DM, Traver D, Ferrando AA, Kutok JL, Aster JC, Kanki JP, et al. Myc-induced T cell leukemia in transgenic zebrafish. Science. 2003;299:887–90.
Girardi T, Vicente C, Cools J, De Keersmaecker K. The genetics and molecular biology of T-ALL. Blood Am Soc Hematol. 2017;129:1113–23.
De Keersmaecker K, Real PJ, Gatta G D, Palomero T, Sulis ML, Tosello V, et al. The TLX1 oncogene drives aneuploidy in T cell transformation. Nat Med. 2010;16:1321–7.
Durinck K, Van Loocke W, Van der Meulen J, Van de Walle I, Ongenaert M, Rondou P, et al. Characterization of the genome-wide TLX1 binding profile in T-cell acute lymphoblastic leukemia. Leukemia. 2015;29:2317–27.
Van Vlierberghe P, Palomero T, Khiabanian H, Van der Meulen J, Castillo M, Van Roy N, et al. PHF6 mutations in T-cell acute lymphoblastic leukemia. Nat Genet. 2010;42:338–42.
Wendorff AA, Quinn SA, Rashkovan M, Madubata CJ, Ambesi-Impiombato A, Litzow MR, et al. Phf6 loss enhances HSC self-renewal driving tumor initiation and leukemia stem cell activity in T-ALL. Cancer Disco. 2019;9:436–51.
Hsu YC, Chen TC, Lin CC, Yuan CT, Hsu CL, Hou HA, et al. Phf6-null hematopoietic stem cells have enhanced self-renewal capacity and oncogenic potentials. Blood Adv. 2019;3:2355–67.
Meacham CE, Lawton LN, Soto-Feliciano YM, Pritchard JR, Joughin BA, Ehrenberger T, et al. A genome-scale in vivo loss-of-function screen identifies phf6 as a lineage-specific regulator of leukemia cell growth. Genes Dev. 2015;29:483–8.
Soto-Feliciano YM, Bartlebaugh JME, Liu Y, Sánchez-Rivera FJ, Bhutkar A, Weintraub AS, et al. PHF6 regulates phenotypic plasticity through chromatin organization within lineage-specific genes. Genes Dev. 2017;31:973–89.
Thakral D, Kaur G, Gupta R, Benard-Slagter A, Savola S, Kumar I, et al. Rapid identification of key copy number alterations in B- and T-cell acute lymphoblastic leukemia by digital multiplex ligation-dependent probe amplification. Front Oncol. 2019;9:871.
Garcia EG, Iyer S, Garcia SP, Loontiens S, Sadreyev RI, Speleman F, et al. Cell of origin dictates aggression and stem cell number in acute lymphoblastic leukemia. Leukemia. 2018;32:1860–5.
Borga C, Park G, Foster C, Burroughs-Garcia J, Marchesin M, Ahmed ST, et al. Simultaneous B and T cell acute lymphoblastic leukemias in zebrafish driven by transgenic MYC: implications for oncogenesis and lymphopoiesis. Leukemia. 2019;33:1.
De Keersmaecker K, Ferrando AA. TLX1-induced T-cell acute lymphoblastic leukemia. Clin Cancer Res. 2011;17:6381–6.
Chen E, Lim MS, Rosic-Kablar S, Liu J, Jolicoeur P, Dubé ID, et al. Dysregulated expression of mitotic regulators is associated with B-cell lymphomagenesis in HOX11-transgenic mice. Oncogene. 2006;25:2575–87.
Kawabe T, Muslin AJ, Korsmeyer SJ. HOX11 interacts with protein phosphatases PP2A and PP1 and disrupts a G2/M cell-cycle checkpoint. Nature. 1997;385:454–8.
Frazer JK, Meeker ND, Rudner L, Bradley DF, Smith ACH, Demarest B, et al. Heritable T-cell malignancy models established in a zebrafish phenotypic screen. Leukemia. 2009;23:1825–35.
Ribeiro D, Melão A, van Boxtel R, Santos CI, Silva A, Silva MC, et al. STAT5 is essential for IL-7–mediated viability, growth, and proliferation of T-cell acute lymphoblastic leukemia cells. Blood Adv. 2018;2:2199–213.
Xie M, Lu C, Wang J, McLellan MD, Johnson KJ, Wendl MC, et al. Age-related mutations associated with clonal hematopoietic expansion and malignancies. Nat Med. 2014;20:1472–8.
Pinz S, Unser S, Rascle A. Signal transducer and activator of transcription STAT5 is recruited to c-Myc super-enhancer. BMC Mol Biol. 2016;17. https://doi.org/10.1186/s12867-016-0063-y
Bempt M V, Demeyer S, Broux M, Bie JD, Bornschein S, Mentens N, et al. Cooperative enhancer activation by TLX1 and STAT5 drives development of NUP214-ABL1/TLX1-positive T cell acute lymphoblastic leukemia. Cancer Cell. 2018;34:271–85.e7.
We would like to thank our zebrafish caretaker Karen Vermeulen for all her nurturing work. In addition, we would like to thank following agencies for funding reagents, zebrafish facility costs, and personnel expenses: FWO Vlaanderen (Fund for scientific research Flanders) (post)doctoral grants for SL, SV, and KD, FWO research project GO37918N; GOA: BOF16/GOA/023; BOF: 01J15119; Villa Joep; Kinderkankerfonds; Kom op tegen kanker: Emmanuel van der Schueren grant for LD and SL; Stichting tegen kanker project number: F/2014/373; the computational resources (Stevin Supercomputer Infrastructure) and services used in this work were provided by the VSC (Flemish Supercomputer Center), funded by Ghent University, FWO and the Flemish Government—department EWI. DML is funded by NIH (R01CA211734) and the MGH Research Scholars Program. JKF and his laboratory were supported by the OUHSC Jimmy Everest Section of Pediatric Hematology-Oncology and grants from Hyundai Hope On Wheels, the Oklahoma Center for the Advancement of Science and Technology (HRP-067), and an INBRE pilot project award from the National Institute of General Medical Sciences (P20 GM103447). JKF holds the Children’s Hospital Foundation E.L. and Thelma Gaylord Endowed Chair in Pediatric Hematology-Oncology. Research reported in this publication was supported in part by the National Cancer Institute Cancer Center Support Grant P30CA225520 awarded to the University of Oklahoma Stephenson Cancer Center and used the Molecular Biology Shared Resource. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
Conflict of interest
The authors declare that they have no conflict of interest.
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Loontiens, S., Vanhauwaert, S., Depestel, L. et al. A novel TLX1-driven T-ALL zebrafish model: comparative genomic analysis with other leukemia models. Leukemia 34, 3398–3403 (2020). https://doi.org/10.1038/s41375-020-0938-2